Sarepta Therapeutics
S&P 600
$20.45
-0.34%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.54.
- Comfortable interest cover: operating profit covers interest about 18.4 times.
- Current assets comfortably cover current liabilities (current ratio 2.32).
!Watch-points
- Return on equity is on the lower side at -46.7%.
- Return on capital employed is on the lower side at -33.4%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-0.65
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Piotroski F-ScoreWeak
3 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$2.16B
Current Price$ 20.45
High / Low$ 25.32 / 14.68
Stock P/E-5.20
Book Value$ 14.49
Dividend Yield0%
ROCE-33.43%
ROE-46.70%
Debt to Equity0.54
Current Ratio2.32
P/B Ratio1.4137573
EPS$ -3.93
Debt$828.97M
PAT Margin-38.27%
Cash PAT$-668.89M
ICR18.35